Advantest has significantly outperformed key peer Teradyne over the last 5 years, by increasing market share and boosting its earnings trajectory. Current market conditions are difficult, but the ...
Advantest (TSE:6857) shares have been on many investors’ radars lately, especially given their strong returns over the past three and 12 months. Some are curious how these gains compare to the company ...
Advantest's reported earnings deteriorated for the first two quarters of FY23, with earnings for the first half of the FY down 60%. The stock market has not followed the decline in earnings because it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results